pillbase.ru

Remifentanil Hydrochloride

Active substance: remifentanil

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · REMIFENTANIL HYDROCHLORIDE 1 mg/mL

United StatesActive

Marketing holder: Fresenius Kabi USA, LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Ремифентанил
    лиофилизат для приготовления концентрата для приготовления раствора для внутривенного введения, 2 мг, 2.194 мг (original in Russian, GRLS)
    ЛП-№(006578)-(РГ-RU)
    Федеральное государственное унитарное предприятие "МОСКОВСКИЙ ЭНДОКРИННЫЙ ЗАВОД" (ФГУП "ЭНДОФАРМ")
Import and control

Control by country

  • RussiacontrolledSchedule: НII

    Source: GRLS (Russian state register) · record 01a120c3-7d88-7c6e-a30a-b53aef8ffc28;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United StatescontrolledSchedule: CII

    Source: openFDA NDC · record 01a1208c-8f95-7964-88fe-6a7c8e137fdf,01a1208f-a5aa-7629-b535-f6f1c72d504f,01a12094-534a-78e6-89dd-f1f0acd42b81,01a12094-5350-7b40-b2e1-130c40804a20,01a12099-02e0-7bc3-a123-43bc41a21eb5;count=12 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
63323-724
Registration status
Active
Dispensing
Prescription only
Control marker
CII
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 63323-724 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 63323-724 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 63323-724 · Verified 2026-10-09 · open in source